Eating Behavior Strategies for Childhood Obesity
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how different eating behaviors and food access affect childhood obesity. Researchers will examine how controlling or not controlling access to favorite foods influences children's weight and eating habits. Families will participate in two periods: one with limited access to certain foods (Restricted Access Period) and another with free access (Non-Restricted Access Period). Children aged 8-11 who are at risk for obesity or already have obesity and consume certain foods at least twice a week may be suitable for this study. As an unphased study, this trial offers families the chance to contribute to valuable research that could shape future strategies for managing childhood obesity.
Will I have to stop taking my current medications?
If your child is taking medications that affect appetite, such as Ritalin, Adderall, Concerta, Wellbutrin, or Prednisone, they will not be able to participate in the study.
What prior data suggests that these eating behavior strategies are safe for children?
Research shows that time-restricted feeding is generally safe for adults with obesity, with studies finding no major negative effects. Although this trial uses a slightly different method, involving periods when certain foods are restricted, similar approaches are often well-tolerated by children and teenagers.
While this specific trial lacks direct data, related studies in children have examined time-restricted eating and found no major safety issues. Participants in those studies typically experienced safe outcomes, including some weight loss and improvements in health measures like body fat and blood sugar levels.
Overall, related research generally considers the strategies used in this trial safe for children. Careful monitoring during the trial ensures safety and effectiveness.12345Why are researchers excited about this trial?
Researchers are excited about the Eating Behavior Strategies for Childhood Obesity trial because it explores a unique behavioral approach to managing childhood obesity. Unlike traditional treatments such as dietary changes, exercise programs, or medication, this trial focuses on altering food access through periods of restriction and structured intake. This method could offer a more natural and sustainable way to help children develop healthier eating habits by changing their food environment and preferences. By involving parents directly in managing food access, this trial aims to empower families to take proactive steps in addressing obesity, potentially leading to long-lasting behavioral changes.
What evidence suggests that this trial's treatments could be effective for childhood obesity?
Research has shown that time-restricted eating, which involves eating only during certain hours of the day, can aid in weight management. Studies have found that teenagers following this eating pattern lost weight and improved their blood sugar levels. One study reported a noticeable drop in body mass index (BMI) in young people after 12 weeks of intermittent fasting, which is similar to time-restricted eating. However, some research suggests that time-restricted eating might not be more effective for weight loss than eating throughout the day. Its success can depend on personal habits and adherence. In this trial, participants will undergo a Behavioral restriction arm, where their parents will restrict preferred foods for 2 weeks, to evaluate the impact on eating behaviors and weight management.16789
Who Is on the Research Team?
Katherine Balantekin, PhD, RD
Principal Investigator
Clinical Associate Professor
Are You a Good Fit for This Trial?
This trial is for children aged 8-11 who are at risk for obesity or already obese, partly based on their own BMI or their parent's weight. They must enjoy at least half of the study foods and eat them twice a week. Kids with clinical eating disorders, allergies to study foods, not liking most study foods, or taking appetite-affecting meds can't join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants complete consent, height/weight/body fat measurements, questionnaires, and tasks including delayed discounting and relative reinforcing value tasks.
Randomized Cross-over Design
Participants undergo two weeks of restricted access and two weeks of non-restricted access, with a one-week washout period in between, including loss of control test meals.
Follow-up
Participants are monitored for changes in zBMI and body fat percentage, with follow-up visits at 6 and 12 months for measurements and tasks.
What Are the Treatments Tested in This Trial?
Interventions
- Non-Restricted Access Period
- Restricted Access Period
Find a Clinic Near You
Who Is Running the Clinical Trial?
State University of New York at Buffalo
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator